Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
missed the second dose of Shingrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a 73-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received the 1st dose of Shingrix vaccine 13 months ago with batch number 274YD and expiry date 15 September 2025). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: missed the second dose of Shingrix ). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 02-APR-2025 The physician assistant reported that a 73 years old female patient missed the second dose of Shingrix, it had been almost 13 months since dose 1. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.